Fairvalue-Calculator Fairvalue-Calculator
EN DE

Spineway SA (ALSPW) Fair Value & Analysis

Healthcare · FR · Market cap €4.6M

Price€0.1226
Fair Value€0.4600
Upside+275.2%
Quality95/100
Evidence: Low Range €0.2100 – €0.7900

Fair value as of: Jun 26, 2026

Analysis

Spineway SA (ALSPW) currently trades at €0.1226, while our model-based Fair Value estimate is €0.4600 — implying the stock looks roughly 275.2% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -62% EssilorLuxottica Société anonyme (ESLOF) -44% HOYA Corporation (HOCPY) -42% Medline Inc (MDLN) -15% Becton, Dickinson and Company (BDX) -22% Alcon Inc (ALC) -44%

Frequently asked questions

Is Spineway SA (ALSPW) undervalued?
As of Jun 26, 2026, our model estimates a fair value of €0.4600 versus a price of €0.1226 — about +275% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ALSPW?
Our 21-model fair value for Spineway SA is €0.4600 (as of Jun 26, 2026), built from audited fundamentals. The current price is €0.1226.
What is the quality score of ALSPW?
Spineway SA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.